on Thursday fully approved the Alzheimer’s drug Leqembi, amid concerns about its safety, cost and accessibility.has been granted full regulatory approval. Other approved drugs only target its symptoms.
The treatment could"give people in the early stages of Alzheimer’s more time to maintain their independence and do the things they love," Joanne Pike, president and CEO of the Alzheimer’s Association, said in a statement.How does Leqembi help Alzheimer's patients?that focused on how well patients performed in six categories: memory, orientation, judgment and problem solving, community affairs, home and hobbies, and personal care.
"In real-world terms, this likely means more time for the patient to be living independently, enjoying their hobbies, their friends and having a better quality of life," Wilcock said."Time will tell how much, but the clinical trial did show significant benefit on activities of daily living measures."Others, however, were less rosy about Leqembi's benefits.
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: abc15 - 🏆 263. / 63 Read more »
Source: wjxt4 - 🏆 246. / 63 Read more »
Source: CNBC - 🏆 12. / 72 Read more »
Source: bbchealth - 🏆 143. / 63 Read more »